ReviewPublished 11 May 2026Sequence-dominant protein therapeutics: mechanistic foundations for efficient biologics developmentSarfaraz K. NiaziFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1781560
ReviewPublished 30 April 2026From biosimilars to breakthroughs: regulatory convergence toward evidence-efficient development of monoclonal antibodiesSarfaraz K. NiaziFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1778468
